U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6293874

User-operated amusement apparatus for kicking the user's buttocks

An apparatus including a user-operated and controlled apparatus for self-infliction of repetitive blows to the user's buttocks by a plurality of elongated arms bearing flexible extensions that rotate under the user's control.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 540/555 - Polycyclo ring system which contains the hetero ring as one of the cyclos


Subclass of Class 540 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the hetero ring is one of the cyclos of
No. of patents: 111
Last issue date: 03/02/2010


1      
NumberTitleIssue Date
7671196Diazepinoquinolines, synthesis thereof, and intermediates thereto
The present invention relates to methods for synthesizing compounds useful as 5HT2C agonists or partial agonists, derivatives thereof, and to intermediates thereto. ...
03/02/2010
7432256Substitued imidazo [1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
The present invention is concerned with substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the formula I wherein R1 is hydrogen, halogen, lower alkyl, lower alkyl subs...
10/07/2008
7390797Fused indazole compounds
The present invention provides a novel fused indazole compound having an excellent JNK inhibitory action. More specifically, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. ...
06/24/2008
7384934Piperazine substituted aryl benzodiazepines
Described herein are compounds of formula (I) wherein: is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, S, and O; Alk is (C1-4) alkylene or hydroxy substituted (C1-4)...
06/10/2008
7351839Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives
This invention provides processes for preparing compounds formula: wherein R is H, alkyl, acyl, aryl, aroyl or —C(O)R′; R′ is alkyl or aryl; R1, R2, R4 and R5 are H, —OH, ...
04/01/2008
7273861Non-nucleoside reverse transcriptase inhibitors
Compounds represented by formula 1: wherein R1 is H, halogen, (C1-4)alkyl, O(C1-4)alkyl, and haloalkyl; R2 is H or methyl; R3 is H or (C1-4)alkyl;...
09/25/2007
7271163Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R
09/18/2007
7271164Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives
This invention provides compounds of the formula: wherein R1 and R2 are each, independently, H, alkyl, cycloalkyl, —CH2-cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, â€...
09/18/2007
7271162Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides compounds of formula I having the structure wherein: R1 and R2 are H, alkyl, cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —S...
09/18/2007
7153350Water soluble colorants for ink jet printing
In accordance with one embodiment of the present invention, a colorant in an ink jet ink formulation is disclosed. The colorant comprises an organic dye chromophore with at least one functional group Y containing one or more primary, secondary or tertiary amino grou...
12/26/2006
7141563Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi] indole derivatives
This invention provides processes for preparing compounds formula: wherein R is H, alkyl, acyl, aryl, aroyl or —C(O)R′; R′ is alkyl or aryl; R1, R2, R4 and R5 are...
11/28/2006
7129237[1,4]Diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
Compounds of Formula I or a pharmaceutically acceptable salt thereof are provided: where R1 through R7 are defined herein. The compounds of Formula I are 5HT2c agonists or partial agonists, ...
10/31/2006
7109314Fluorescent nucleotides
According to the present invention, there is provided a fluorescent nucleotide represented by the formula: A-B-C, wherein A represents a residue of natural or synthetic nucleotide, oligonucleotide, polynucleotide, or derivative thereof, and binds to B at a ba...
09/19/2006
7105506Tetracyclic compounds as PDE5-inhibitors
Compounds of structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents. ...
09/12/2006
70711851,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
Compounds of Formula I or a pharmaceutically acceptable salt thereof are provided: where R1 through R7 are defined herein. The compounds of Formula I are 5HT2c agonists or partial ago...
07/04/2006
7026311Dibenzodiazepine derivatives, their preparation and use
The invention relates to compounds of the formula I and their tautomeric forms, possible enantiomeric and diastereomeric forms and their prodrugs, and to their preparation and use, where A, B, R1 and X1 ...
04/11/2006
7015213Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
The invention concerns the use of pyrido-thieno-triazolo-diazepins for preparing a medicine for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors. The invention also concerns novel pyrido-thieno-tria...
03/21/2006
6943171Polycyclic guanine derivative phosphodiesterase V inhibitors
A compound having the formula (Ia) or (b), salt or solvate thereof, with the variables as defined herein, which can inhibit selectively phosphodiesterase V and can be useful for treating sexual dysfunction and other physiological disorders, symptoms and diseases:
09/13/2005
6936604Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
The invention is directed to bridged bicyclic amino acid-derived [1,4]benzodiazepine compounds, intermediates and pharmaceutical compositions thereof useful as vasopressin receptor antagonists and methods for treating vasopressin mediated disorders. ...
08/30/2005
6922375Super-thin hanging clock
A super-thin hanging clock includes a housing, a transparent cover, and a core that has a first shell, a second shell fitted with the first shell and having a swingable lid to hide the battery and a through hole for the button to pass through, a stator, a PC board w...
07/26/2005
6916922Process for the preparation of 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta [B] [1,4] diazepino- [6,7,1-hi] indole derivatives
This invention provides a process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole derivatives of the general formula: wherein: R is H, alkyl, cycloalkyl, —CH...
07/12/2005
6858604Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides compounds of the formula: wherein R1 and R2 are each, independently, H, alkyl, cycloalkyl, —CH2-cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—...
02/22/2005
6784172Processes for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides processes for synthesizing compounds of formula I: wherein R is H or alkyl; R1, R2 are H, alkyl, alkoxy, halogen, fluorinated alkyl, —CN, alkyl sulfonamide, alkyl amide, am...
08/31/2004
6784292Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof
The invention relates to a method for the preparation of compound of formula (1). The invention further relates to the previously unknown compounds of formulas (5 and 6) as intermediates in the production of benzodiazepines of formula (1). ...
08/31/2004
6777407Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R3 are each, independently, hydrogen, ...
08/17/2004
6759405Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
This invention provides compounds of formula I having the structure wherein: R1 and R2 are H, alkyl, cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —SO2
07/06/2004
6743789Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives
The present invention is a compound of formula The compound and derivatives or pharmaceutically acceptable salts thereof of the invention have a good affinity and selectivity to the GABA A α5 receptor and are useful for...
06/01/2004
6743785Agents and methods for the treatment of proliferative diseases
The present invention provides selective kinase inhibitors of formula (I). ...
06/01/2004
6608193Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
Methods of preparing amino-substituted-tetrahydroisoquinoline ring compounds include the steps of providing a support-bound amino-substituted-tetrahydroisoquinoline compound; forming an intermediate by reacting the support-bound amino-substituted-tetrahyd...
08/19/2003
6576764Synthesis and crystallization of piperazine ring-containing compounds
The present invention is directed to methods for the preparation of piperazine ring-containing compounds, particularly mirtazapine. According to the present invention, the mirtazapine intermediate 1-(3-carboxypyridyl-2)-4-methyl-2-phenyl-piperazine is mad...
06/10/2003
6545149Synthesis and crystallization of piperazine ring-containing compounds
The present invention is directed to methods for the preparation of piperazine ring-containing compounds, particularly mirtazapine. According to the present invention, the mirtazapine intermediate 1-(3-carboxypyridyl-2)-4-methyl-2-phenyl-piperazine is mad...
04/08/2003
6433167Triazolo-1,4-diazepine compounds and medicinal composition containing the same
A triazolo-1,4-diazepine compound having the formula (I): ##STR1## wherein A represents CO, CO--B, or B, B represents a C1 to C6 alkylene group or a C2 to C6 alkylene group having an oxygen atom interposed in th...
08/13/2002
6414144Process for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi] indole derivatives
The present invention provides processes for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b][1, 4]diazepino[6, 7, 1-hi]indole derivatives of the general formula: ##STR1## wherein: R is H, alkyl, acyl, or aroyl; R1, R
07/02/2002
6323197Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors
The invention concerns compounds of formula (I), in which R1, R2, R3 and R4 mean hydrogen or different substituents; X means hydrogen or halogen; Y means C1-6 alkoxy or X and Y together mean --O--(CH
11/27/2001
6288094Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
The invention relates to polycyclic thiazolidin-2-ylidene amines and their physiologically tolerated salts and physiologically functional derivatives. Polycyclic thiazolidin-2-ylidene amines of the formula I, ##STR1## in which the radicals have the stated...
09/11/2001
6277984Monomethine cyanines rigidized by a two-carbon chain
Fluorescent monomethine cyanine complexes rigidized a two-carbon alkyl group between the nitrogen's of the cyanine's heterocycles are provided and having the structure ##STR1## wherein R1 through R7 represent various selected groups ...
08/21/2001
6255488Bicyclic amidines, process for their preparation, and their use as catalyst
The process for the preparation of bicyclic amidines of the general formula: ##STR1## wherein A is selected from the group consisting of --CR1 R2 --CR3 R4 --CR5 R6 --, --CR1 R
07/03/2001
6159996Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals
Polycyclic thiazolidin-2-ylidene amines and their physiologically tolerable salts and physiologically functional derivatives of the formula I ##STR1## in which the radicals have the meanings indicated, and their physiologically tolerable salts and a ...
12/12/2000
6156747Isoxazolidine derivatives
This invention concerns the compounds of formula (I), ##STR1## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is zero to 6; p is zero to 3; q is zero to 3; r is zero to 3; ...
12/05/2000
6110910Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
This invention relates to carbocyclic and heterocyclic fused-ring quinolinecarboxylic acid compounds, to pharmaceutical compositions comprising such compounds, and to methods of using such compounds for the treatment and/or prevention of organ transplanta...
08/29/2000
1      
 
Sign InRegister
Username  
Password   
forgot password?